{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:15:22Z","timestamp":1783606522302,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijcrp.2026.200586","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:27:49Z","timestamp":1770337669000},"page":"200586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Official proceeding from the 2025 ITACARE-P National Meeting, Rome, October 21-22 2025: The added value of Cardiovascular Rehabilitation in heart failure management: clinical scenarios and expert opinion from a centres network of the Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P)"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-2621","authenticated-orcid":false,"given":"Matteo","family":"Ruzzolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuccia","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pistono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Werren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giallauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fattirolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcrp.2026.200586_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the secondary prevention and rehabilitation section of the European association of preventive cardiology","volume":"28","author":"Ambrosetti","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200586_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.hfc.2021.01.007","article-title":"Exercise-based cardiac rehabilitation programs in heart failure patients","volume":"17","author":"Patti","year":"2021","journal-title":"Heart Fail. Clin."},{"issue":"36","key":"10.1016\/j.ijcrp.2026.200586_bib3","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200586_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2459\/JCM.0b013e3283620533","article-title":"ISYDE-2008 investigators of the Italian association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR). Cardiac rehabilitation in chronic heart failure: data from the Italian SurveY on carDiac rEhabilitation (ISYDE-2008)","volume":"15","author":"Giallauria","year":"2014","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.ijcrp.2026.200586_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-025-10521-2","article-title":"Exercise prescriptions for ischemic cardiomyopathy: a scoping review","author":"Koskina","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcrp.2026.200586_bib6","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/ejhf.3046","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure \u2013 2023 Cochrane systematic review and meta-analysis","volume":"25","author":"Molloy","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcrp.2026.200586_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006798","article-title":"Cardiac rehabilitation and long-term prognosis in patients with heart failure","volume":"13","author":"Kamiya","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcrp.2026.200586_bib8","first-page":"CD003331","article-title":"Exercise based rehabilitation for heart failure","volume":"3","author":"Rees","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcrp.2026.200586_bib9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/2047487319854140","article-title":"Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: the Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF): a systematic review and meta-analysis","volume":"27","author":"Bjarnason-Wehrens","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200586_bib10","article-title":"Exercise-based cardiac rehabilitation in adults with heart failure","volume":"3","author":"Molloy","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcrp.2026.200586_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.121.054117","article-title":"One-year committed exercise training reverses abnormal left ventricular myocardial stiffness in patients with stage B heart failure with preserved ejection fraction","volume":"144","author":"Hieda","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2026.200586_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.124.070064","article-title":"Exercise training in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction: a randomized clinical trial","volume":"151","author":"Gudmundsdottir","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2026.200586_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hlc.2017.07.002","article-title":"Mechanisms of the improvement in peak VO2 with exercise training in heart failure with reduced or preserved ejection fraction","volume":"27","author":"Tucker","year":"2018","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ijcrp.2026.200586_bib14","series-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","year":"2021"},{"key":"10.1016\/j.ijcrp.2026.200586_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41569-021-00611-7","article-title":"The role of cardiac rehabilitation in improving cardiovascular outcomes","volume":"19","author":"Taylor","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200586_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-003139","article-title":"Effectiveness of the innovative Austrian phase III cardiac rehabilitation model on cardiovascular risk factors: a nationwide registry","volume":"12","author":"Reich","year":"2025","journal-title":"Open Heart"},{"key":"10.1016\/j.ijcrp.2026.200586_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1253\/circrep.CR-24-0106","article-title":"Phase III cardiac rehabilitation: ambulatory heart groups\u2015a model from Germany","volume":"6","author":"Nebel","year":"2024","journal-title":"Circ. Rep."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200586_bib18","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1097\/HCR.0000000000000930","article-title":"Core components of cardiac rehabilitation programs: 2024 update: a scientific statement from the American heart association and the American association of cardiovascular and pulmonary rehabilitation: endorsed by the American college of cardiology","volume":"45","author":"Brown","year":"2025","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200586_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: EAPC position paper 2020","volume":"28","author":"Ambrosetti","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200586_bib20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/2047487312449597","volume":"21","author":"Piepoli","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200586_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/2047487320924912","volume":"28","author":"Abreu","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"36","key":"10.1016\/j.ijcrp.2026.200586_bib22","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200586_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40292-025-00707-y","article-title":"Monitoring the effects of cardiac rehabilitation programs in heart failure patients: the role of biomarkers","volume":"32","author":"Gallo","year":"2025","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200586_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ejhf.3646","volume":"27","author":"Rosano","year":"2025","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.ijcrp.2026.200586_bib25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart failure association of the ESC","volume":"25","author":"Bayes-Genis","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcrp.2026.200586_bib26","doi-asserted-by":"crossref","unstructured":"Byung-Su Yoo,1,2 Hyun-Suk Jung,1 Jang-Young Kim,1 Seung-Hwan Lee,1 Sung-Oh Hwang,3 Junghan Yoon,1 Kyung-Hoon CHoe1; 1Cardiology, Yonsei University, Wonju College of Medicine, Wonju, Kangwondo; 2RRC of MOST & KOSEF, Research Institute of Med. eng. & Rehab.(RIMIRE), Wonju, Kangwondo, Republic of Korea; 3Emergency Medicine, Yonsei University, Wonju College of Medicine, Wonju, Kangwondo, Republic of Korea. The \u2018Gray Zone\u2019 of diagnosis using a plasma BNP levels for congestive heart failure. J. Card. Fail., volume 10, issue 4, S48. https:\/\/doi.org\/10.1016\/j.cardfail.2004.06.110.","DOI":"10.1016\/j.cardfail.2004.06.110"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200586_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10741-023-10340-3","article-title":"Heart failure study group of the Italian society of cardiology. Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy","volume":"29","author":"Dini","year":"2024","journal-title":"Heart Fail. Rev."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200586_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ejhf.3165","article-title":"Use of natriuretic peptides and echocardiography for diagnosing heart failure","volume":"26","author":"Talha","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcrp.2026.200586_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.amjcard.2023.07.177","article-title":"Clinical correlates and prognostic value of B-Type natriuretic peptide in left ventricular assist device recipients with cardiogenic shock: insights from INTERMACS","volume":"205","author":"Shetty","year":"2023","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200586_bib30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1741826711409171","article-title":"Individual patient meta-analysis of exercise training effects on systemic brain natriuretic peptide expression in heart failure","volume":"19","author":"Smart","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"Issue 4","key":"10.1016\/j.ijcrp.2026.200586_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ihj.2024.07.011","article-title":"Prognostic utility of B-type natriuretic peptide and 6-min walk test in patients with acute decompensated heart failure","volume":"76","author":"Verma","year":"2024","journal-title":"Indian Heart J."},{"key":"10.1016\/j.ijcrp.2026.200586_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00408-018-0111-0","article-title":"Effect of 6-min walk test on pro-BNP levels in patients with pulmonary arterial hypertension","volume":"196","author":"Pathak","year":"2018","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200586_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3349\/ymj.2010.51.2.151","article-title":"Interpretation and use of natriuretic peptides in non-congestive heart failure settings","volume":"51","author":"Tsai","year":"2010","journal-title":"Yonsei Med. J."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200586_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100691","article-title":"BNP\/NT-proBNP levels are sensitive markers of impaired prognosis in patients without heart failure","volume":"2","author":"Volpe","year":"2023","journal-title":"JACC Adv"},{"issue":"13","key":"10.1016\/j.ijcrp.2026.200586_bib35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200586_bib36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00380-022-02025-y","article-title":"Urine albumin-to-creatinine ratio on admission predicts early rehospitalization in patients with acute decompensated heart failure","volume":"37","author":"Matsumoto","year":"2022","journal-title":"Heart Vessel."},{"issue":"20","key":"10.1016\/j.ijcrp.2026.200586_bib37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"American heart association. Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2026.200586_bib38","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200586_bib39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"EMPEROR-reduced trial investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200586_bib40","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200586_bib41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200586_bib42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2026.200586_bib43","unstructured":"2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure."},{"key":"10.1016\/j.ijcrp.2026.200586_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcte.2024.100335","article-title":"SGLT2 inhibitors: beyond glycemic control","volume":"35","author":"Hasan","year":"2024","journal-title":"Journal of Clinical & Translational Endocrinology"},{"key":"10.1016\/j.ijcrp.2026.200586_bib45","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2337\/dc20-1675","article-title":"Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA-HF","volume":"44","author":"Inzucchi","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200586_bib46","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ejhf.2149","article-title":"Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction","volume":"23","author":"Packer","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200586_bib47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10741-023-10325-2","article-title":"Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy","volume":"28","author":"Malgie","year":"2023","journal-title":"Heart Fail. Rev."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200586_bib48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ejhf.2206","article-title":"Patient profiling in heart failure for tailoring medical therapy. A consensus document of the heart failure association of the European society of cardiology","volume":"23","author":"Rosano","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200586_bib49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2025.0686","article-title":"SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors","volume":"185","author":"Wing","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ijcrp.2026.200586_bib50","article-title":"SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria: a meta-analysis","author":"Neuen","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ijcrp.2026.200586_bib51","article-title":"Effects of sodium glucose cotransporter 2 inhibitors by diabetes status and level of albuminuria: a meta-analysis","author":"Staplin","year":"2025","journal-title":"JAMA"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:24:51Z","timestamp":1783603491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S2772487526000164"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200586","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Official proceeding from the 2025 ITACARE-P National Meeting, Rome, October 21-22 2025: The added value of Cardiovascular Rehabilitation in heart failure management: clinical scenarios and expert opinion from a centres network of the Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200586"}}